AdvisorShares Files ETF Targeting Peptides and Human Enhancement

The AdvisorShares Peptide and Human Enhancement ETF (LOOK) focuses on the growing peptide and human-enhancement economy. The actively-managed fund will invest at least 80% of assets in companies tied to peptide therapeutics, manufacturing and delivery, or areas such as metabolic health, fitness, aesthetics, regenerative medicine, neurotechnology, longevity, wearables and telehealth. Its mandate spans large- through micro-cap stocks, including ADRs, and may target both established market leaders and lesser-known growth companies. At least 25% of assets will be concentrated in pharmaceuticals, biotechnology and life sciences. The non-diversified strategy may trade frequently and can also seek out-of-favor stocks viewed as undervalued.